Male 129/SV mice

↑ Endpoint	Organ	Obs. Time	Dose [%]
↑ Endpoint	Organ	Obs. Time	0	0.005	0.02
N	-	-	4	4	4
spleen CD19+ cells	spleen	10 days	100	98 (-2%)^a	57 (-43%)^b,c
spleen CD4+ cells	spleen	10 days	100	85 (-15%)^a	59 (-41%)^b,c
spleen CD8+ cells	spleen	10 days	100	93 (-7%)^a	63 (-37%)^b,c
spleen Pan-NK+ cells	spleen	10 days	100	109 (9%)^a	59 (-41%)^b,c
spleen cellularity	spleen	10 days	100	97 (-3%)^a	59 (-41%)^b,c
spleen: absolute weight	spleen	10 days	59.3 ± 4	62 ± 8 (5%)^a	46.3 ± 6 (-22%)^b,c
thymus CD4+ cells	thymus	10 days	100	105 (5%)^a	57 (-43%)^b,c
thymus CD8+ cells	thymus	10 days	100	117 (17%)^a	67 (-33%)^b,c
thymus DN (CD4-CD8-) cells	thymus	10 days	100	67 (-33%)^a	33 (-67%)^b,c
thymus DP (CD4+CD8+) cells	thymus	10 days	100	105 (5%)^a	27 (-73%)^b,c
thymus cellularity	thymus	10 days	100	104 (4%)^a	31 (-69%)^b,c
thymus: absolute weight	thymus	10 days	32 ± 10	32 ± 4 (0%)^a	21 ± 4 (-34%)^b,c
^a NOEL (No observed effect level) ^b Significantly different from control (p < 0.05) ^c LOEL (Lowest observed effect level)

Endpoints which have no dose-response data extracted.